y5
2304444-48-0
|
Y6-OD-2Br
2418532-43-9
|
Org OD 13-0
4781-53-7
|
Cyclohexanol-OD
121621-82-7
|
Neuropeptide Y5 receptor ligand-1
322723-35-3
|
propionic acid-od
21388-62-5
|
dichloroacetic acid-od
82093-18-3
|
Dimethyl Hemiorthoformiat (OD)
73761-37-2
|
3-nitrobenzyl alcohol-od
117897-59-3
|
N-ethyl-2-fluoro-N-(trifluoromethyl)aniline
1420855-29-3
|
7-ethyl-8-methyl-6-oxo-N-(o-tolyl)-2,3,4,6-tetrahydropyrimido[2,1-b][1,3]thiazine-3-carboxamide
1396862-13-7
|
methyl 7-fluoro-1-((2-methoxyphenethyl)carbamoyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate
1396581-23-9
|
3-chloro-N-ethyl-N-(trifluoromethyl)aniline
1420988-15-3
|
methyl 1-(benzo[d][1,3]dioxol-5-ylcarbamoyl)-7-fluoro-3,4-dihydroisoquinoline-2(1H)-carboxylate
1351581-57-1
|
methyl 1-((2-chloro-5-(trifluoromethyl)phenyl)carbamoyl)-7-fluoro-3,4-dihydroisoquinoline-2(1H)-carboxylate
1396555-93-3
|
methyl 7-fluoro-1-((6-methylpyridin-2-yl)carbamoyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate
1396630-36-6
|
methyl 7-fluoro-1-((4-methylpyrimidin-2-yl)carbamoyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate
1396559-84-4
|
N-ethyl-3-(methylthio)-N-(trifluoromethyl)aniline
1420813-20-2
|
4-bromo-N-ethyl-N-(trifluoromethyl)aniline
213190-29-5
|
